Editorial: Use of probiotics for treatment of chemotherapy-induced diarrhea: Is it a myth?

Journal of Parenteral and Enteral Nutrition

Volumn 33, Issue 5, 2009, Pages 573-574

  Miller, Andrew C ^a   Elamin, Elamin M ^b,c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE PLUS DIPHENOXYLATE; FLUOROURACIL; IRINOTECAN; LOPERAMIDE; OCTREOTIDE; PROBIOTIC AGENT; ANTINEOPLASTIC AGENT;

ABDOMINAL DISCOMFORT; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; COLORECTAL CANCER; DIARRHEA; EDITORIAL; GASTROINTESTINAL TOXICITY; HUMAN; IRRITABLE COLON; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PRIORITY JOURNAL; SUPPLEMENTATION; ULCERATIVE COLITIS; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; FEMALE; NOTE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DIARRHEA; FEMALE; HUMANS; PROBIOTICS;

EID: 69949100774     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607109336596     Document Type: Editorial

References (10)

1. Keefe DM, Gibson RJ, Hauer-Jensen M. Gastrointestinal mucositis. Semin Oncol Nurs. 2004 ; 20: 38-47.
2. Duncan M., Grant G. Oral and intestinal mucositis-causes and possible treatments. Aliment Pharmacol Ther. 2003 ; 18: 853-874.
3. Takasuna K., Hagiwara T., Watanabe K., et al. Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea. Cancer Chemother Pharmacol. 2006: 58: 494-503.
4. Arbuckle RB, Huber SL, Zacker C. The consequences of diarrhea occurring during chemotherapy for colorectal cancer: a retrospective study. Oncologist. 2000 ; 5: 250-259.
5. Dranitsaris G., Maroun J., Shah A. Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea. Can J Gastroenterol. 2005 ; 19: 83-87. (Pubitemid 40392721)
6. Von Bültzingslöwen I., Adlerberth I., Wold AE, Dahlén G., Jontell M. Oral and intestinal microflora in 5-fluorouracil treated rats, trans-location to cervical and mesenteric lymph nodes and effects of probiotic bacteria. Oral Microbiol Immunol. 2003 ; 18: 278-284.
7. Bowen JM, Stringer AM, Gibson RJ, Yeoh AS, Hannam S., Keefe DM VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol Ther. 2007 ; 6: 1449-1454.
8. Österlund P., Ruotsalainen T., Korpela R., et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer. 2007 ; 97: 1028-1034.
9. National Cancer Institute. NCI drug dictionary: VSL#3. http://www.cancer.gov/Templates/drugdictionary.aspx?searchTxt= VSL%233&sgroup=Starts+with.
10. Abd El-Atti S., Wasicek K., Mark S., Hegazi R. The usage of probiotics in the management of chemotherapy induced diarrhea: a case study JPEN J Parenter Enteral Nutr. IN PRESS: doi: 10.1177/0148607109332004.